QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ETON

QT60Eton Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
32.48
-0.28-0.85%
OverviewShort InterestFilings
ETONQT60Eton Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
32.48-0.85%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.06
Insider Own44.43%
Shs Outstand27.39M
Perf Week1.15%
Market Cap897.37MForward P/E17.11EPS next Y1.90Insider Trans0.47%Shs Float-Perf Month-1.25%
Enterprise Value889.96MPEG47.48EPS next Q0.13Inst Own-Short Float-Perf Quarter56.38%
Income-1525535.00P/S10.32EPS this Y1437.83%Inst Trans-Short Ratio-Perf Half Y103.64%
Sales86.93MP/B29.20EPS next Y136.45%ROA-1.51%Short Interest-Perf YTD92.08%
Book/sh0.88P/C56.43EPS next 5Y70.54%ROE-5.68%52W High35.66 -8.92%Perf Year138.65%
Cash/sh0.91P/FCF58.15EPS past 3/5Y-ROIC3.10%52W Low13.09 148.13%Perf 3Y-
Dividend Est.-EV/EBITDA163.18Sales past 3/5Y56.18% -Gross Margin54.77%Volatility3.13% 3.74%Perf 5Y-
Dividend TTM-EV/Sales10.24EPS Y/Y TTM53.33%Oper. Margin2.35%ATR (14)1.67Perf 10Y-
Dividend Ex-Date-Quick Ratio0.88Sales Y/Y TTM120.51%Profit Margin-1.70%RSI (14)59.84Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.21EPS Q/Q-28.57%SMA204.74%Beta0.50Target Price57.00
Payout0.00%Debt/Eq0.40Sales Q/Q41.18%SMA5012.18%Rel Volume1.54Prev Close32.76
Employees31LT Debt/Eq0.85EarningsAug 06SMA20056.82%Avg Volume393.45KPrice32.48
IPO DateNov 13, 2018Option/ShortYes / YesEPS/Sales Surpr.-50.00% 9.09%Net Debt/EBITDA-1.36Volume607,178Change-0.85%
Analyst Ratings
DateActionAnalystRatingTarget
May-15-26ReiteratedH.C. WainwrightBuy$52 → $57
May-29-25ReiteratedH.C. WainwrightBuy$33 → $35
Oct-28-24ReiteratedCraig-HallumBuy$8.00 → $15
Oct-04-24ReiteratedH.C. WainwrightBuy$9.00 → $11
May-06-24InitiatedCraig-HallumBuy$8.00
Jul-25-22ReiteratedH.C. WainwrightBuy$9.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue868039
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A403716
Gross Profit484323
Selling, General and Administrative Excl. Other373623
Research and Development983
Other Operating Expense-1-10
Operating Income20-3
Interest Expense252
Unusual Expense
———
Non-Operating Income (Expense)10-1
Net Income Before Taxes-2-5-4
Income Taxes
000
Consolidated Net Income-2-5-4
Net Income From Continuing Operations-2-5-4
Net Income-2-5-4
EPS (Recurring)-0.05-0.17-0.15
EPS (Basic, Before Extraordinaries)-0.05-0.17-0.15
EPS (Diluted)-0.06-0.17-0.15
EBITDA64-1
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio10.205.71—
Gross Margin55.8153.7558.97
Operating Margin2.330.00-7.69
Net Margin-2.33-6.25-10.26
Shares Outstanding272726
Market Capitalization877457—
Operating Lease Expense
———
Insider Trading Volume
$33.81$31.12$28.43$25.75$23.06● Close Price0.00M1.76M3.53M5.29M7.06MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Adams Jennifer McKieDirectorJun 17 '26Option Exercise3.78100,000378,00050,000Jun 17 12:00 AM
Adams Jennifer McKieDirectorJun 17 '26Sale32.4850,0001,623,7950Jun 17 12:00 AM
BRYNJELSEN SEANPresident & CEOMay 28 '26Sale31.88120,0003,825,717833,694May 29 12:00 AM
Krempa DavidChief Business OfficerMay 27 '26Option Exercise2.1839,35885,758118,406May 27 12:00 AM
Krempa DavidChief Business OfficerMay 27 '26Sale31.4719,679619,37525,249May 27 12:00 AM
Krempa DavidChief Business OfficerMay 26 '26Option Exercise1.3875,048103,31662,773May 27 12:00 AM
Krempa DavidChief Business OfficerMay 26 '26Sale31.4937,5241,181,73225,249May 27 12:00 AM
Krempa DavidChief Business OfficerMay 22 '26Option Exercise3.5861,182219,032125,609May 27 12:00 AM
Krempa DavidChief Business OfficerMay 22 '26Sale33.3942,7971,428,81625,249May 27 12:00 AM
RIEDEL NORBERT GDirectorApr 21 '26Option Exercise8.1064,310521,21067,155Apr 22 12:00 AM
RIEDEL NORBERT GDirectorFeb 03 '26Option Exercise4.4260,000265,20035,000Feb 05 12:00 AM
Gruber James R.Chief Financial OfficerAug 20 '25Sale16.022,63142,149204,753Aug 20 12:00 AM
Gruber James R.Chief Financial OfficerAug 19 '25Sale16.1639,082631,565205,299Aug 20 12:00 AM
Krempa DavidChief Business OfficerJun 16 '25Sale14.7310,223150,585612,646Jun 16 12:00 AM
Krempa DavidChief Business OfficerJun 13 '25Sale14.776,800100,436622,869Jun 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR